Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
17.87
-1.38 (-7.17%)
At close: Apr 10, 2026, 4:00 PM EDT
17.58
-0.29 (-1.62%)
After-hours: Apr 10, 2026, 5:12 PM EDT
KMTS Stock Forecast
Stock Price Forecast
The 4 analysts that cover KMTS stock have a consensus rating of "Buy" and an average price target of $26.75, which forecasts a 49.69% increase in the stock price over the next year. The lowest target is $17 and the highest is $32.
Price Target: $26.75 (+49.69%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KMTS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | -4.87% | Apr 9, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +79.07% | Apr 7, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +79.07% | Mar 25, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +79.07% | Mar 18, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $25 | Hold | Maintains | $22 → $25 | +39.90% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
92.76M
from 59.82M
Increased by 55.07%
Revenue Next Year
94.83M
from 92.76M
Increased by 2.24%
EPS This Year
-2.36
from -5.13
EPS Next Year
-2.40
from -2.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| High | 96.1M | 97.8M | |||||
| Avg | 92.8M | 94.8M | |||||
| Low | 88.5M | 91.0M |
Revenue Growth
| Revenue Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| High | 60.6% | 5.4% | |||||
| Avg | 55.1% | 2.2% | |||||
| Low | 48.0% | -1.9% |
EPS Forecast
| EPS | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 |
|---|---|---|---|---|---|---|
| High | -2.43 | -2.42 | ||||
| Avg | -2.36 | -2.40 | ||||
| Low | -2.27 | -2.34 |
EPS Growth
| EPS Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.